December 23, 2024Open Access

The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score–Matched Study

Key Points

Key points are not available for this paper at this time.

Abstract

Nirmatrelvir-ritonavir was associated with decreased risk of hospitalization within 30 days and 1-year risk of MACE and death in patients with CKD and kidney failure.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Ian A. Strohbehn

University of Vermont

Tianqi Ouyang

Harvard University

Meghan Lee

Massachusetts General Hospital

Journals

Open Forum Infectious Diseases

Actions

Institutions

Massachusetts General Hospital

Brookline Public Schools

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score–Matched Study

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study